0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Peptide Screening Service Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-19G14564
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Peptide Screening Service Market Research Report 2023
BUY CHAPTERS

Global Peptide Screening Service Market Research Report 2025

Code: QYRE-Auto-19G14564
Report
June 2025
Pages:98
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Peptide Screening Service Market Size

The global market for Peptide Screening Service was valued at US$ 1274 million in the year 2024 and is projected to reach a revised size of US$ 2440 million by 2031, growing at a CAGR of 9.7% during the forecast period.

Peptide Screening Service Market

Peptide Screening Service Market

Peptide screening service refers to the use of high-throughput technology (such as phage display peptide library, mRNA display, chemical synthesis peptide library screening, etc.) or computational biology methods (such as molecular docking, virtual screening, machine learning model prediction) to systematically screen candidate peptide molecules with specific biological functions (such as high affinity binding to target proteins, regulation of cell signaling pathways, antibacterial and antiviral activity, etc.) or physicochemical properties (such as stability, membrane permeability) from a large-scale peptide sequence collection, and combine experimental verification (such as ELISA, SPR, cell activity detection, etc.) to evaluate their activity and specificity, and ultimately provide customized solutions for lead peptide sequences or functional peptide libraries for application fields such as drug development (such as peptide drugs, vaccine adjuvants), biomaterial design (such as targeted delivery carriers), and diagnostic reagent development. By integrating multi-dimensional screening strategies and activity verification systems, this service significantly shortens the research and development cycle from random peptide libraries to functional peptide molecules, and increases the possibility of discovering highly effective and low-toxic peptide drugs.
Peptide screening service refers to the use of high-throughput technology (such as phage display peptide library, mRNA display, chemical synthesis peptide library screening, etc.) or computational biology methods (such as molecular docking, virtual screening, machine learning model prediction) to systematically screen candidate peptide molecules with specific biological functions (such as high affinity binding to target proteins, regulation of cell signaling pathways, antibacterial and antiviral activity, etc.) or physicochemical properties (such as stability, membrane permeability) from a large-scale peptide sequence collection, and combine experimental verification (such as ELISA, SPR, cell activity detection, etc.) to evaluate their activity and specificity, and ultimately provide customized solutions for lead peptide sequences or functional peptide libraries for application fields such as drug development (such as peptide drugs, vaccine adjuvants), biomaterial design (such as targeted delivery carriers), and diagnostic reagent development. By integrating multi-dimensional screening strategies and activity verification systems, this service significantly shortens the research and development cycle from random peptide libraries to functional peptide molecules, and increases the possibility of discovering highly effective and low-toxic peptide drugs.
This report aims to provide a comprehensive presentation of the global market for Peptide Screening Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide Screening Service.
The Peptide Screening Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peptide Screening Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peptide Screening Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Peptide Screening Service Market Report

Report Metric Details
Report Name Peptide Screening Service Market
Accounted market size in year US$ 1274 million
Forecasted market size in 2031 US$ 2440 million
CAGR 9.7%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company JPT Peptide Technologies, Biosynth, Orbit Discovery, Creative Biolabs, GenScript, Creative Peptides, Eurogentec, Bio-Synthesis, Antibody Design Labs, HLA Proteins, Synbio Technologies, Lugen SCI, Quimigen, IRBM, New England Peptide
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Peptide Screening Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Peptide Screening Service Market growing?

Ans: The Peptide Screening Service Market witnessing a CAGR of 9.7% during the forecast period 2025-2031.

What is the Peptide Screening Service Market size in 2031?

Ans: The Peptide Screening Service Market size in 2031 will be US$ 2440 million.

Who are the main players in the Peptide Screening Service Market report?

Ans: The main players in the Peptide Screening Service Market are JPT Peptide Technologies, Biosynth, Orbit Discovery, Creative Biolabs, GenScript, Creative Peptides, Eurogentec, Bio-Synthesis, Antibody Design Labs, HLA Proteins, Synbio Technologies, Lugen SCI, Quimigen, IRBM, New England Peptide

What are the Application segmentation covered in the Peptide Screening Service Market report?

Ans: The Applications covered in the Peptide Screening Service Market report are Peptide Drug Development, Vaccine Development, Others

What are the Type segmentation covered in the Peptide Screening Service Market report?

Ans: The Types covered in the Peptide Screening Service Market report are Solid Phase Screening, Solution Phase Screening, Cell-based Screening

Recommended Reports

Peptide Analytics

Peptide Synthesis

Protein & Drug Screening

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peptide Screening Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Solid Phase Screening
1.2.3 Solution Phase Screening
1.2.4 Cell-based Screening
1.3 Market by Application
1.3.1 Global Peptide Screening Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Peptide Drug Development
1.3.3 Vaccine Development
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peptide Screening Service Market Perspective (2020-2031)
2.2 Global Peptide Screening Service Growth Trends by Region
2.2.1 Global Peptide Screening Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Peptide Screening Service Historic Market Size by Region (2020-2025)
2.2.3 Peptide Screening Service Forecasted Market Size by Region (2026-2031)
2.3 Peptide Screening Service Market Dynamics
2.3.1 Peptide Screening Service Industry Trends
2.3.2 Peptide Screening Service Market Drivers
2.3.3 Peptide Screening Service Market Challenges
2.3.4 Peptide Screening Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peptide Screening Service Players by Revenue
3.1.1 Global Top Peptide Screening Service Players by Revenue (2020-2025)
3.1.2 Global Peptide Screening Service Revenue Market Share by Players (2020-2025)
3.2 Global Top Peptide Screening Service Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Peptide Screening Service Revenue
3.4 Global Peptide Screening Service Market Concentration Ratio
3.4.1 Global Peptide Screening Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peptide Screening Service Revenue in 2024
3.5 Global Key Players of Peptide Screening Service Head office and Area Served
3.6 Global Key Players of Peptide Screening Service, Product and Application
3.7 Global Key Players of Peptide Screening Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Peptide Screening Service Breakdown Data by Type
4.1 Global Peptide Screening Service Historic Market Size by Type (2020-2025)
4.2 Global Peptide Screening Service Forecasted Market Size by Type (2026-2031)
5 Peptide Screening Service Breakdown Data by Application
5.1 Global Peptide Screening Service Historic Market Size by Application (2020-2025)
5.2 Global Peptide Screening Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Peptide Screening Service Market Size (2020-2031)
6.2 North America Peptide Screening Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Peptide Screening Service Market Size by Country (2020-2025)
6.4 North America Peptide Screening Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Peptide Screening Service Market Size (2020-2031)
7.2 Europe Peptide Screening Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Peptide Screening Service Market Size by Country (2020-2025)
7.4 Europe Peptide Screening Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peptide Screening Service Market Size (2020-2031)
8.2 Asia-Pacific Peptide Screening Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Peptide Screening Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Peptide Screening Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Peptide Screening Service Market Size (2020-2031)
9.2 Latin America Peptide Screening Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Peptide Screening Service Market Size by Country (2020-2025)
9.4 Latin America Peptide Screening Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peptide Screening Service Market Size (2020-2031)
10.2 Middle East & Africa Peptide Screening Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Peptide Screening Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Peptide Screening Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 JPT Peptide Technologies
11.1.1 JPT Peptide Technologies Company Details
11.1.2 JPT Peptide Technologies Business Overview
11.1.3 JPT Peptide Technologies Peptide Screening Service Introduction
11.1.4 JPT Peptide Technologies Revenue in Peptide Screening Service Business (2020-2025)
11.1.5 JPT Peptide Technologies Recent Development
11.2 Biosynth
11.2.1 Biosynth Company Details
11.2.2 Biosynth Business Overview
11.2.3 Biosynth Peptide Screening Service Introduction
11.2.4 Biosynth Revenue in Peptide Screening Service Business (2020-2025)
11.2.5 Biosynth Recent Development
11.3 Orbit Discovery
11.3.1 Orbit Discovery Company Details
11.3.2 Orbit Discovery Business Overview
11.3.3 Orbit Discovery Peptide Screening Service Introduction
11.3.4 Orbit Discovery Revenue in Peptide Screening Service Business (2020-2025)
11.3.5 Orbit Discovery Recent Development
11.4 Creative Biolabs
11.4.1 Creative Biolabs Company Details
11.4.2 Creative Biolabs Business Overview
11.4.3 Creative Biolabs Peptide Screening Service Introduction
11.4.4 Creative Biolabs Revenue in Peptide Screening Service Business (2020-2025)
11.4.5 Creative Biolabs Recent Development
11.5 GenScript
11.5.1 GenScript Company Details
11.5.2 GenScript Business Overview
11.5.3 GenScript Peptide Screening Service Introduction
11.5.4 GenScript Revenue in Peptide Screening Service Business (2020-2025)
11.5.5 GenScript Recent Development
11.6 Creative Peptides
11.6.1 Creative Peptides Company Details
11.6.2 Creative Peptides Business Overview
11.6.3 Creative Peptides Peptide Screening Service Introduction
11.6.4 Creative Peptides Revenue in Peptide Screening Service Business (2020-2025)
11.6.5 Creative Peptides Recent Development
11.7 Eurogentec
11.7.1 Eurogentec Company Details
11.7.2 Eurogentec Business Overview
11.7.3 Eurogentec Peptide Screening Service Introduction
11.7.4 Eurogentec Revenue in Peptide Screening Service Business (2020-2025)
11.7.5 Eurogentec Recent Development
11.8 Bio-Synthesis
11.8.1 Bio-Synthesis Company Details
11.8.2 Bio-Synthesis Business Overview
11.8.3 Bio-Synthesis Peptide Screening Service Introduction
11.8.4 Bio-Synthesis Revenue in Peptide Screening Service Business (2020-2025)
11.8.5 Bio-Synthesis Recent Development
11.9 Antibody Design Labs
11.9.1 Antibody Design Labs Company Details
11.9.2 Antibody Design Labs Business Overview
11.9.3 Antibody Design Labs Peptide Screening Service Introduction
11.9.4 Antibody Design Labs Revenue in Peptide Screening Service Business (2020-2025)
11.9.5 Antibody Design Labs Recent Development
11.10 HLA Proteins
11.10.1 HLA Proteins Company Details
11.10.2 HLA Proteins Business Overview
11.10.3 HLA Proteins Peptide Screening Service Introduction
11.10.4 HLA Proteins Revenue in Peptide Screening Service Business (2020-2025)
11.10.5 HLA Proteins Recent Development
11.11 Synbio Technologies
11.11.1 Synbio Technologies Company Details
11.11.2 Synbio Technologies Business Overview
11.11.3 Synbio Technologies Peptide Screening Service Introduction
11.11.4 Synbio Technologies Revenue in Peptide Screening Service Business (2020-2025)
11.11.5 Synbio Technologies Recent Development
11.12 Lugen SCI
11.12.1 Lugen SCI Company Details
11.12.2 Lugen SCI Business Overview
11.12.3 Lugen SCI Peptide Screening Service Introduction
11.12.4 Lugen SCI Revenue in Peptide Screening Service Business (2020-2025)
11.12.5 Lugen SCI Recent Development
11.13 Quimigen
11.13.1 Quimigen Company Details
11.13.2 Quimigen Business Overview
11.13.3 Quimigen Peptide Screening Service Introduction
11.13.4 Quimigen Revenue in Peptide Screening Service Business (2020-2025)
11.13.5 Quimigen Recent Development
11.14 IRBM
11.14.1 IRBM Company Details
11.14.2 IRBM Business Overview
11.14.3 IRBM Peptide Screening Service Introduction
11.14.4 IRBM Revenue in Peptide Screening Service Business (2020-2025)
11.14.5 IRBM Recent Development
11.15 Eurogentec
11.15.1 Eurogentec Company Details
11.15.2 Eurogentec Business Overview
11.15.3 Eurogentec Peptide Screening Service Introduction
11.15.4 Eurogentec Revenue in Peptide Screening Service Business (2020-2025)
11.15.5 Eurogentec Recent Development
11.16 New England Peptide
11.16.1 New England Peptide Company Details
11.16.2 New England Peptide Business Overview
11.16.3 New England Peptide Peptide Screening Service Introduction
11.16.4 New England Peptide Revenue in Peptide Screening Service Business (2020-2025)
11.16.5 New England Peptide Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Peptide Screening Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Solid Phase Screening
 Table 3. Key Players of Solution Phase Screening
 Table 4. Key Players of Cell-based Screening
 Table 5. Global Peptide Screening Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Peptide Screening Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Peptide Screening Service Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Peptide Screening Service Market Share by Region (2020-2025)
 Table 9. Global Peptide Screening Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Peptide Screening Service Market Share by Region (2026-2031)
 Table 11. Peptide Screening Service Market Trends
 Table 12. Peptide Screening Service Market Drivers
 Table 13. Peptide Screening Service Market Challenges
 Table 14. Peptide Screening Service Market Restraints
 Table 15. Global Peptide Screening Service Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Peptide Screening Service Market Share by Players (2020-2025)
 Table 17. Global Top Peptide Screening Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Screening Service as of 2024)
 Table 18. Ranking of Global Top Peptide Screening Service Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Peptide Screening Service Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Peptide Screening Service, Headquarters and Area Served
 Table 21. Global Key Players of Peptide Screening Service, Product and Application
 Table 22. Global Key Players of Peptide Screening Service, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Peptide Screening Service Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Peptide Screening Service Revenue Market Share by Type (2020-2025)
 Table 26. Global Peptide Screening Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Peptide Screening Service Revenue Market Share by Type (2026-2031)
 Table 28. Global Peptide Screening Service Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Peptide Screening Service Revenue Market Share by Application (2020-2025)
 Table 30. Global Peptide Screening Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Peptide Screening Service Revenue Market Share by Application (2026-2031)
 Table 32. North America Peptide Screening Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Peptide Screening Service Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Peptide Screening Service Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Peptide Screening Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Peptide Screening Service Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Peptide Screening Service Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Peptide Screening Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Peptide Screening Service Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Peptide Screening Service Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Peptide Screening Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Peptide Screening Service Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Peptide Screening Service Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Peptide Screening Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Peptide Screening Service Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Peptide Screening Service Market Size by Country (2026-2031) & (US$ Million)
 Table 47. JPT Peptide Technologies Company Details
 Table 48. JPT Peptide Technologies Business Overview
 Table 49. JPT Peptide Technologies Peptide Screening Service Product
 Table 50. JPT Peptide Technologies Revenue in Peptide Screening Service Business (2020-2025) & (US$ Million)
 Table 51. JPT Peptide Technologies Recent Development
 Table 52. Biosynth Company Details
 Table 53. Biosynth Business Overview
 Table 54. Biosynth Peptide Screening Service Product
 Table 55. Biosynth Revenue in Peptide Screening Service Business (2020-2025) & (US$ Million)
 Table 56. Biosynth Recent Development
 Table 57. Orbit Discovery Company Details
 Table 58. Orbit Discovery Business Overview
 Table 59. Orbit Discovery Peptide Screening Service Product
 Table 60. Orbit Discovery Revenue in Peptide Screening Service Business (2020-2025) & (US$ Million)
 Table 61. Orbit Discovery Recent Development
 Table 62. Creative Biolabs Company Details
 Table 63. Creative Biolabs Business Overview
 Table 64. Creative Biolabs Peptide Screening Service Product
 Table 65. Creative Biolabs Revenue in Peptide Screening Service Business (2020-2025) & (US$ Million)
 Table 66. Creative Biolabs Recent Development
 Table 67. GenScript Company Details
 Table 68. GenScript Business Overview
 Table 69. GenScript Peptide Screening Service Product
 Table 70. GenScript Revenue in Peptide Screening Service Business (2020-2025) & (US$ Million)
 Table 71. GenScript Recent Development
 Table 72. Creative Peptides Company Details
 Table 73. Creative Peptides Business Overview
 Table 74. Creative Peptides Peptide Screening Service Product
 Table 75. Creative Peptides Revenue in Peptide Screening Service Business (2020-2025) & (US$ Million)
 Table 76. Creative Peptides Recent Development
 Table 77. Eurogentec Company Details
 Table 78. Eurogentec Business Overview
 Table 79. Eurogentec Peptide Screening Service Product
 Table 80. Eurogentec Revenue in Peptide Screening Service Business (2020-2025) & (US$ Million)
 Table 81. Eurogentec Recent Development
 Table 82. Bio-Synthesis Company Details
 Table 83. Bio-Synthesis Business Overview
 Table 84. Bio-Synthesis Peptide Screening Service Product
 Table 85. Bio-Synthesis Revenue in Peptide Screening Service Business (2020-2025) & (US$ Million)
 Table 86. Bio-Synthesis Recent Development
 Table 87. Antibody Design Labs Company Details
 Table 88. Antibody Design Labs Business Overview
 Table 89. Antibody Design Labs Peptide Screening Service Product
 Table 90. Antibody Design Labs Revenue in Peptide Screening Service Business (2020-2025) & (US$ Million)
 Table 91. Antibody Design Labs Recent Development
 Table 92. HLA Proteins Company Details
 Table 93. HLA Proteins Business Overview
 Table 94. HLA Proteins Peptide Screening Service Product
 Table 95. HLA Proteins Revenue in Peptide Screening Service Business (2020-2025) & (US$ Million)
 Table 96. HLA Proteins Recent Development
 Table 97. Synbio Technologies Company Details
 Table 98. Synbio Technologies Business Overview
 Table 99. Synbio Technologies Peptide Screening Service Product
 Table 100. Synbio Technologies Revenue in Peptide Screening Service Business (2020-2025) & (US$ Million)
 Table 101. Synbio Technologies Recent Development
 Table 102. Lugen SCI Company Details
 Table 103. Lugen SCI Business Overview
 Table 104. Lugen SCI Peptide Screening Service Product
 Table 105. Lugen SCI Revenue in Peptide Screening Service Business (2020-2025) & (US$ Million)
 Table 106. Lugen SCI Recent Development
 Table 107. Quimigen Company Details
 Table 108. Quimigen Business Overview
 Table 109. Quimigen Peptide Screening Service Product
 Table 110. Quimigen Revenue in Peptide Screening Service Business (2020-2025) & (US$ Million)
 Table 111. Quimigen Recent Development
 Table 112. IRBM Company Details
 Table 113. IRBM Business Overview
 Table 114. IRBM Peptide Screening Service Product
 Table 115. IRBM Revenue in Peptide Screening Service Business (2020-2025) & (US$ Million)
 Table 116. IRBM Recent Development
 Table 117. Eurogentec Company Details
 Table 118. Eurogentec Business Overview
 Table 119. Eurogentec Peptide Screening Service Product
 Table 120. Eurogentec Revenue in Peptide Screening Service Business (2020-2025) & (US$ Million)
 Table 121. Eurogentec Recent Development
 Table 122. New England Peptide Company Details
 Table 123. New England Peptide Business Overview
 Table 124. New England Peptide Peptide Screening Service Product
 Table 125. New England Peptide Revenue in Peptide Screening Service Business (2020-2025) & (US$ Million)
 Table 126. New England Peptide Recent Development
 Table 127. Research Programs/Design for This Report
 Table 128. Key Data Information from Secondary Sources
 Table 129. Key Data Information from Primary Sources
 Table 130. Authors List of This Report


List of Figures
 Figure 1. Peptide Screening Service Picture
 Figure 2. Global Peptide Screening Service Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Peptide Screening Service Market Share by Type: 2024 VS 2031
 Figure 4. Solid Phase Screening Features
 Figure 5. Solution Phase Screening Features
 Figure 6. Cell-based Screening Features
 Figure 7. Global Peptide Screening Service Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Peptide Screening Service Market Share by Application: 2024 VS 2031
 Figure 9. Peptide Drug Development Case Studies
 Figure 10. Vaccine Development Case Studies
 Figure 11. Others Case Studies
 Figure 12. Peptide Screening Service Report Years Considered
 Figure 13. Global Peptide Screening Service Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Peptide Screening Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Peptide Screening Service Market Share by Region: 2024 VS 2031
 Figure 16. Global Peptide Screening Service Market Share by Players in 2024
 Figure 17. Global Peptide Screening Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 18. The Top 10 and 5 Players Market Share by Peptide Screening Service Revenue in 2024
 Figure 19. North America Peptide Screening Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Peptide Screening Service Market Share by Country (2020-2031)
 Figure 21. United States Peptide Screening Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Peptide Screening Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Peptide Screening Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Peptide Screening Service Market Share by Country (2020-2031)
 Figure 25. Germany Peptide Screening Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Peptide Screening Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Peptide Screening Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Peptide Screening Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Peptide Screening Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Peptide Screening Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Peptide Screening Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Peptide Screening Service Market Share by Region (2020-2031)
 Figure 33. China Peptide Screening Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Peptide Screening Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Peptide Screening Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Peptide Screening Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Peptide Screening Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Peptide Screening Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Peptide Screening Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Peptide Screening Service Market Share by Country (2020-2031)
 Figure 41. Mexico Peptide Screening Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Peptide Screening Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Peptide Screening Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Peptide Screening Service Market Share by Country (2020-2031)
 Figure 45. Turkey Peptide Screening Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Peptide Screening Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Peptide Screening Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. JPT Peptide Technologies Revenue Growth Rate in Peptide Screening Service Business (2020-2025)
 Figure 49. Biosynth Revenue Growth Rate in Peptide Screening Service Business (2020-2025)
 Figure 50. Orbit Discovery Revenue Growth Rate in Peptide Screening Service Business (2020-2025)
 Figure 51. Creative Biolabs Revenue Growth Rate in Peptide Screening Service Business (2020-2025)
 Figure 52. GenScript Revenue Growth Rate in Peptide Screening Service Business (2020-2025)
 Figure 53. Creative Peptides Revenue Growth Rate in Peptide Screening Service Business (2020-2025)
 Figure 54. Eurogentec Revenue Growth Rate in Peptide Screening Service Business (2020-2025)
 Figure 55. Bio-Synthesis Revenue Growth Rate in Peptide Screening Service Business (2020-2025)
 Figure 56. Antibody Design Labs Revenue Growth Rate in Peptide Screening Service Business (2020-2025)
 Figure 57. HLA Proteins Revenue Growth Rate in Peptide Screening Service Business (2020-2025)
 Figure 58. Synbio Technologies Revenue Growth Rate in Peptide Screening Service Business (2020-2025)
 Figure 59. Lugen SCI Revenue Growth Rate in Peptide Screening Service Business (2020-2025)
 Figure 60. Quimigen Revenue Growth Rate in Peptide Screening Service Business (2020-2025)
 Figure 61. IRBM Revenue Growth Rate in Peptide Screening Service Business (2020-2025)
 Figure 62. Eurogentec Revenue Growth Rate in Peptide Screening Service Business (2020-2025)
 Figure 63. New England Peptide Revenue Growth Rate in Peptide Screening Service Business (2020-2025)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners